Back to search results
NCT05528237

HPV Self-sampling to Improve Access to Cervical Cancer Screening for Persons With HIV and/or Underserved Individuals

Enrolling by Invitation
NAAges 25+InterventionalScreening
University of Washington
~50 participants
Updated 2022-09-06 on ClinicalTrials.gov
What's tested:Flocked swab paired with Roche Cobas 4800

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of eligible individuals who accept self-sampling kits
Measured over Baseline (during clinical and/or study recruitment encounter)
+5 more outcomes measured

Conditions

Cervical Cancer

Explore related trials

Cervical CarcinomaHIV InfectionHIV InfectionHPV

Where it's being run

3 sites across 1 states
Washington3

Study leadership

  • Darcy Rao, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of Washington

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age \>=25 and \<65 (individuals without diagnosed HIV) or \>=30 years (individuals with diagnosed HIV)
Female sex at birth
Proficient in English or Spanish
Refused a Pap smear or are \>=6 months overdue for cervical cancer screening

Exclusion

Current pregnancy
Complete hysterectomy
History of cervical cancer
Unable to provide informed consent

What this trial measures

  • Proportion of eligible individuals who accept self-sampling kitsBaseline (during clinical and/or study recruitment encounter)

    the proportion of eligible individuals due or overdue for screening who agree to collect a vaginal sample for HPV testing.

  • Proportion of eligible individuals who submit self-sampled specimens3 weeks from enrollment

    the proportion of individuals who agree to self-collection who return samples

  • Satisfaction with self-collectionWithin 2 weeks of sample collection

    Participants will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "I was satisfied with the self-collection experience."

  • Confidence with self-collectionWithin 2 weeks of sample collection

    Participants will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "I am sure I got a good sample using the swab."

  • Recommendation of self-collectionWithin 2 weeks of sample collection

    Participants will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "I would recommend self-collection to a friend."

  • Ease of returning home kitsWithin 2 weeks of sample collection

    Participants who collected a sample at home will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "It was easy to return my sample (by mail or to the clinic)."